Amato RJ - Search Results

1

A 20% dose reduction of the original CISCA/VB regimen allows better tolerance and similar survival rate in disseminated testicular non-seminomatous germ-cell tumors: final results of a phase III randomized trial.

Fizazi K, Do KA, Wang X, Finn L, Logothetis CJ, Amato RJ. Fizazi K, et al. Among authors: amato rj. Ann Oncol. 2002 Jan;13(1):125-34. doi: 10.1093/annonc/mdf005. Ann Oncol. 2002. PMID: 11863094 Free article. Clinical Trial.

2

Early predicted time to normalization of tumor markers predicts outcome in poor-prognosis nonseminomatous germ cell tumors.

Fizazi K, Culine S, Kramar A, Amato RJ, Bouzy J, Chen I, Droz JP, Logothetis CJ. Fizazi K, et al. Among authors: amato rj. J Clin Oncol. 2004 Oct 1;22(19):3868-76. doi: 10.1200/JCO.2004.04.008. Epub 2004 Aug 9. J Clin Oncol. 2004. PMID: 15302906

3

Cisplatin combination chemotherapy for elderly patients with urothelial tumours.

Sella A, Logothetis CJ, Dexeus FH, Amato R, Finn L, Fitz K. Sella A, et al. Br J Urol. 1991 Jun;67(6):603-7. doi: 10.1111/j.1464-410x.1991.tb15224.x. Br J Urol. 1991. PMID: 2070205

4

Phase II study of coumarin and cimetidine in patients with metastatic renal cell carcinoma.

Dexeus FH, Logothetis CJ, Sella A, Fitz K, Amato R, Reuben JM, Dozier N. Dexeus FH, et al. J Clin Oncol. 1990 Feb;8(2):325-9. doi: 10.1200/JCO.1990.8.2.325. J Clin Oncol. 1990. PMID: 2137163

5

Chemotherapy immediately after surgery for patients with germ cell tumors.

Sella A, Logothetis CJ, Dexeus FH, Amato R. Sella A, et al. Urology. 1990 Sep;36(3):264-6. doi: 10.1016/0090-4295(90)80270-w. Urology. 1990. PMID: 2168105

6

Phase II study of ketoconazole combined with weekly doxorubicin in patients with androgen-independent prostate cancer.

Sella A, Kilbourn R, Amato R, Bui C, Zukiwski AA, Ellerhorst J, Logothetis CJ. Sella A, et al. J Clin Oncol. 1994 Apr;12(4):683-8. doi: 10.1200/JCO.1994.12.4.683. J Clin Oncol. 1994. PMID: 7512126 Clinical Trial.

7

A phase I trial of intermittent high-dose alpha-interferon and dexamethasone in metastatic renal cell carcinoma.

Amato R, Meyers C, Ellerhorst J, Finn L, Kilbourn R, Sella A, Logothetis C. Amato R, et al. Ann Oncol. 1995 Nov;6(9):911-4. doi: 10.1093/oxfordjournals.annonc.a059358. Ann Oncol. 1995. PMID: 8624294 Free article. Clinical Trial.

8

Optimal delivery of perioperative chemotherapy: preliminary results of a randomized, prospective, comparative trial of preoperative and postoperative chemotherapy for invasive bladder carcinoma.

Logothetis C, Swanson D, Amato R, Banks M, Finn L, Ayala A, Ro J, Babaian R, Dinney C, Ellerhorst J, Hall C, von Eschenbach A. Logothetis C, et al. J Urol. 1996 Apr;155(4):1241-5. doi: 10.1016/s0022-5347(01)66230-x. J Urol. 1996. PMID: 8632540 Clinical Trial.

9

Predictive factors for effective salvage therapy of nonseminomatous germ cell tumors of testis.

Dimopoulos MA, Amato RJ, Logothetis CJ. Dimopoulos MA, et al. Among authors: amato rj. Urology. 1991 Oct;38(4):351-4. doi: 10.1016/0090-4295(91)80151-v. Urology. 1991. PMID: 1661457

10

A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors.

Logothetis CJ, Dexeus FH, Finn L, Sella A, Amato RJ, Ayala AG, Kilbourn RG. Logothetis CJ, et al. Among authors: amato rj. J Clin Oncol. 1990 Jun;8(6):1050-5. doi: 10.1200/JCO.1990.8.6.1050. J Clin Oncol. 1990. PMID: 2189954 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

271 results

Search Page

Filters